Canadian Pharma Stocks: 5 Biggest Companies in 2024
The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…
6,782$
0,48%
Echtzeit-Aktienkurs Amneal Pharmaceuticals
Bid:
Ask:
Nachrichten zur Amneal Pharmaceuticals Aktie
Amneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript
…
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Amneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to resolve claims it…
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 55.56% and 5.80%, respectively, for the quarter ended March 2024. Do the…
Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0%
The Global Testosterone Replacement Therapy Market Size was Valued at USD 1.98 Billion in 2023 and the Worldwide Testosterone Replacement…
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Bausch (BHC) initiates litigation against Amneal Pharmaceuticals and its subsidiaries over a generic version of its lead drug Xifaxan.…
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82%
The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…
Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023 By Investing.com
Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023…
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript
…
Amneal Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 100% and 2.17%, respectively, for the quarter ended December 2023. Do the…
Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203
MONTREAL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical…
AMNEAL INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) and Encourages Investors with Losses to Contact the Firm
PHILADELPHIA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Amneal Pharmaceuticals, Inc.…
Amneal Pharmaceuticals: By Most Measures, A Fundamentally Undervalued Company
…
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript
…
Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
…
JPMorgan Overhauls Loan for Amneal Pharmaceuticals After Investor Backlash
A leveraged loan deal from Amneal Pharmaceuticals LLC has been revamped after facing investor pushback.…
Form 10-Q Amneal Pharmaceuticals, For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharma Shares Rise 24% After 2Q Revenue Beat, Higher Guidance
Amneal Pharma Shares Rise 24% After 2Q Revenue Beat, Higher Guidance...…
Amneal (AMRX) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Amneal (AMRX) give insight into how the company performed in the quarter ended June 2023, but…
Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 90% and 6.50%, respectively, for the quarter ended June 2023. Do the…
Form 8-K Amneal Pharmaceuticals, For: Aug 04
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.09, revenue of $599M beats by $33.89M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharmaceuticals Q2 2023 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Why Shares of Amneal Pharmaceuticals Are Plunging Wednesday
The company received a complete response letter from the FDA regarding a Parkinsons disease generic therapy....…
MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall, Wednesday, 7/5/2023
Stocks that traded heavily or had substantial price changes Wednesday: MP Materials, Wolfspeed rise; Amneal, Knight-Swift fall...…
Amneal Pharmaceuticals Shares Slide 16% After FDA Rejects Parkinsons Drug
Amneal Pharmaceuticals Shares Slide 16% After FDA Rejects Parkinson's Drug...…
Amneal Pharmaceuticals: FDA Requests Additional Information on IPX203 Ingredient
Amneal Pharmaceuticals: FDA Requests Additional Information on IPX203 Ingredient...…
Amneal Pharma Receives Approvals for Generic Drug Applications
Amneal Pharma Receives Approvals for Generic Drug Applications...…
Amneal granted FDA nod for chemotherapy injection
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharmaceuticals Gets FDA Approval for Injectable Tumor Treatment
Amneal Pharmaceuticals Gets FDA Approval for Injectable Tumor Treatment...…
Form 8-K Amneal Pharmaceuticals, For: May 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Amneal Pharmaceuticals, For: May 05
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharmaceuticals Non-GAAP EPS of $0.12 beats by $0.02, revenue of $558M beats by $15.82M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for
Amneal (AMRX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Amneal Pharmaceuticals Shares Rise on Strong 1Q Revenue Projection
Amneal Pharmaceuticals Shares Rise on Strong 1Q Revenue Projection...…
Amneal Pharmaceuticals’ stock soars 14% premarket after company offers upbeat Q1 guidance
Amneal Pharmaceuticals Inc.’s stock AMRX soared 14% in premarket trade Monday, after the generics and specialty pharmaceuticals company offered first-quarter…
Form 8-K Amneal Pharmaceuticals, For: Apr 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal pops 3% after early look at Q1 results, re-affirms FY23 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Expert Ratings for Amneal Pharmaceuticals
Latest Ratings for AMRX
DateFirmActionFromTo Mar 2021Goldman SachsUpgradesSellBuy Dec 2020GuggenheimUpgradesNeutralBuy Nov 2020SVB LeerinkMaintainsMarket Perform
View…
Amneal Pharmaceuticals stock price target cut to $4 from $5 at Truist
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Gene therapy developer AskBio appoints ex Amneal commercial chief as CEO
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-K Amneal Pharmaceuticals, For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue Estimates
Amneal (AMRX) delivered earnings and revenue surprises of 9.52% and 4.91%, respectively, for the quarter ended December 2022. Do the…
Amneal Pharmaceuticals Non-GAAP EPS of $0.23 beats by $0.02, revenue of $610M beats by $30.07M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharmaceuticals Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Intercept Pharma gains after patent settlement with Amneal
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amneal Pharma reaffirms 2022 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…